Maternal exposure during pregnancy: FDA reporting patterns
87,041 FDA FAERS reports mention Maternal exposure during pregnancy. 68,096 reports have a serious outcome flag.
Medicines named as suspect
- Certolizumab Pegol: 9,693 reports
- Adalimumab: 8,645 reports
- Infliximab: 7,273 reports
- Prednisone: 7,216 reports
- Acetaminophen: 7,020 reports
- Etanercept: 6,790 reports
- Rituximab: 6,787 reports
- Methotrexate: 6,712 reports
- Hydroxychloroquine: 6,303 reports
- Leflunomide: 6,271 reports
- Folic Acid: 6,262 reports
- Tocilizumab: 6,175 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.